For Patients
Learn About Expanded Access
- Find information about FDA’s expanded access policies and requirements for enrolling in expanded access programs
-
Expanded Access (Compassionate Use) FDA Encourages More Participation, Diversity in Clinical Trials These research studies are essential. -
FDA Encourages More Participation, Diversity in Clinical Trials Sign Up for the FDA Patient Network Newsletter
- View the January 18, 2017 FDA Patient Network Newsletter
-
Patient Network Newsletter Comment on Current FDA Draft Guidances Read FDA Federal Register Notices and submit your comments on current FDA draft guidances and other policy related questions that affect patients and caregivers. -
Comment on Current FDA Draft Guidances
Navigate the For Patients Section
Find information about the Office of Health and Constituent Affairs, Patient Liaison Program. You can also listen to webinar's offered by FDA experts.
Calendar of Public MeetingsParticipate or find information on an upcoming FDA sponsored workshop, conference or advisory committee meeting.
Comment on Current FDA Draft GuidancesRead FDA Federal Register Notices and submit your comments on current FDA draft guidances and other policy related questions that affect patients and caregivers.
Get Illness/Condition InformationFDA brings the patient perspective into the review of medical products that treat Cancer, Cardiovascular disease, Diabetes, Hepatitis B & C, HIV/AIDS and other illnesses.
Clinical trials, informed consent and FDA's role in ensuring that people of different demographics are included in clinical trials (FDASIA section 907).
Learn About Drug and Device ApprovalsFDA is speeding up the approval process for Drugs and Medical Devices. Learn how medical products are approved.
Learn About Other Treatment OptionsExpanded access, investigational new drugs and off-label use of approved products.
Learn About Patient Engagement at the FDALearn about the FDA Patient Representative Program and discover other ways that patients and caregivers are working with the FDA to have their voice included in medical product approvals and FDA policy.
FDA Patient Specific E-mail List Updates
- FDA's Patient Network Newsletter
Sign Up for our bi-weekly email newsletter that provides information about product safety, drug shortages, product approvals, upcoming meetings, and more. FDA CardioBeat
Updates on safety and regulatory issues related to Cardiovascular Disease, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.- FDA Diabetes Monitor
Updates on safety and regulatory issues related to Diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances. Hepatitis B and C Updates 
Late breaking information, as well as an archival record of updates on safety and regulatory issues related to Hepatitis B and CHIV/AIDS Updates
Updates on important safety and regulatory issues related to HIV, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.FDA Office of Minority Health Email Updates
Updates on health and safety information that are important to minority communities, and a quarterly newsletter detailing upcoming issues and opportunities for you to inform future directions in research.Subscribe to MedWatch Safety Aletrts
Safety alerts delivered to your inbox. To subscribe, just provide your e-mail address. E-list managed by GovDelivery.
